人工尿道括约肌植入术治疗男性尿失禁的初步疗效分析

Implantation of artificial urinary sphincter for treatment of male patients with incontinence

目的探讨人工尿道括约肌(AUS)植入术治疗男性尿失禁的初步疗效及安全性。方法回顾性分析本中心自2013年11月至2017年11月收治的共5例接受AUS植入术患者的临床资料。收集患者手术前后尿垫使用情况及相应评分改善情况,并比较其差异。结果5例患者均为男性,且均为前列腺癌根治术后出现尿失禁,年龄71~78岁,平均75.4岁。所有患者均可激活括约肌装置,术后平均随访28.4个月,4例达到社交控尿标准,其中1例达到完全干燥。发生并发症2例,1例机械故障,更换全套装置后可达社交控尿标准,另1例原因不明。结论AUS植入术是一种安全、有效的治疗中重度尿失禁的方法。

Objective To investigate an initial therapeutic effect and safety of an implantation of artificial urinary sphincter(AUS)for treatment of male incontinence. Methods Clinical data of 5 male patients hospitalized in our center from November 2013 to November 2017 and treated with AUS were retrospectively analyzed.The usage of pads and the improvement of relevant score were compared before and after operation. Results The 5 males had incontinence secondary to post-prostatectomy, aged 71-78 years with an average of 75.4 years.All AUS devices were successfully activated and manipulated.After implantation, patients were followed up for a mean of 28.4 months.A social continence was got in four cases, a totally dry in one case.Complications occurred in 2 cases: 1 case had mechanical failure and reached the standard of social urine control after replacing devices;another case had an unknown cause. Conclusions AUS implantation is a safe and effective treatment for male patients with the moderate to severe urinary incontinence.